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Abstract
Cyclodextrins (CDs) are cyclic oligosaccharides produced by enzymatic degradation of 
starch. The most common CDs are the main natural ones, α, β and γ, which are consti-
tuted of 6, 7 and 8 glucopyranose units, respectively. The CD structure forms a torus or 
doughnut ring and the molecule actually exists as a truncated cone. The outer side of the 
toroid is hydrophilic in nature due to the hydroxyl groups of the glucopyranose units 
while the internal cavity is relatively apolar. Thus, CDs have a high potential to entrap 
entirely or partially a wide variety of compounds in a process known as complexation. 
This gives them new physico-chemical properties and characteristics. The main appli-
cations of CDs in drug formulation rely on CD complexation and include the protec-
tion of easily oxidizable molecules or the improvement of aqueous solubility. The use of 
CDs in analytical chemistry is based on his host-guest recognition property, known as 
supramolecular complex formation. Currently, CDs are successfully used in molecular 
recognition-based methods like chromatographic separations, spectroscopic and electro-
analyses. Quiral analytical separations are a CD area of special relevance. In this work, 
attention is paid to more recent references, especially to selected reviews.
Keywords: cyclodextrins, applications, encapsulation, controlled release, nano, food, 
cosmetic
1. Introduction
Cyclodextrins (CDs) at times referred as Schardinger sugars or cycloamylose dextrins, were 
fortuitously discovered [1, 2] by Vielliers in 1891, who named these compounds as “cellulos-
ing.” Later on Schardinger, who is considered the founder of CD chemistry, gave a detailed 
description about preparation and separation of CD and, more recently, Kurkov and Loftsson 
[3] also made significant contributions to CD science.
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Franz Schardinger, studying microorganisms which play a role in the deterioration of 
foods and by action of cyclodextrinase-Bacillus macerans amylase on the starch, obtained 
two distinct crystalline substances with similar properties to the already known partial 
degradation products of starch, the dextrins, so he named them α-, and β-dextrin. The 
separation of the cycloalkyls may be carried out by selective precipitation by means of 
organic compounds or by high temperature chromatography on a cellulose column. 
French et al. demonstrated that CDs are cyclic oligosaccharides composed of several D-(+)-
glucopyranose units in the form of a saddle [4]. In the second half of the 1930s, Freudenberg 
and his co-workers elucidated the cyclic structure of α-, and β-dextrin [5]. They consist 
of (α-1,4)-linked glucose units. A Greek letter preceding the abbreviation CD—for cyclo-
dextrin—indicates the number of glucose units (α for 6, β for 7, and γ for 8) entering the 
composition of the cycloamylose. CDs constituted of less than 6 glucopyranose units can-
not be formed due to steric hindrances [6]. Approximately, 1500 CD derivatives have been 
reported [7] in the literature.
CDs have a truncated cone appearance [7–12], and a doughnut, toroidal- or cylinder-like 
shape, due to the spatial arrangement characteristic of the various functional groups of the 
glucose units. As a consequence of this conformation, all the secondary hydroxyl groups (cor-
responding to the C2 and C3 carbon atoms of the glucose units) are at one of the edges of the 
cavity, whereas the primary hydroxyls are in the other end of the cavity. Rotation of these 
–OH groups reduces the effective size of the cavity, making it have a more open conical trun-
cated aspect [13] toward the side of the secondary hydroxyls (Figures 1 and 2).
This spatial arrangement gives an apolar character to the interior of the cavity, whereas 
the presence of the –OH groups at the edges of the cone trunk makes them very water 
soluble. For instance, hydrophobic hosts will be housed inside the cavity because of the 
hydrophobic van der Waals type interactions, whereas simultaneously polar interactions 
Figure 1. Molecular structure of (a) α, (b) β, and (c) γ-CDs.
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can be established by the formation of hydrogen bridges between polar hosts and –OH of 
the primary hydroxyls. An endless number of physical and chemical processes [10, 14] are 
usually facilitated, that is, volatile substances may be stabilized by transforming in crystal-
line substances; oxygen-sensitive materials could find protection against oxidation; solubil-
ity and bioavailability of drugs could be improved [15–20] by participating in controlled 
delivery processes.
CDs have been the subject of a large number of studies dealing with complexation and molec-
ular catalysis [21–25], as well as studies about hydrophobic effects and fine-tune models of 
biological processes. In 1953, the first patent on CDs and complexes was registered, but until 
1970, only small amounts of relatively pure CDs were produced for industrial use due to their 
high production cost. Although in the beginning it was erroneously thought that CDs were 
toxic, currently, it is difficult to imagine a world without CDs [3] due to their potential use 
[26]. The number of possible applications seems to be unlimited, i.e., computer-aided drug 
design, pharmaceutical, medical, biomedical and biotechnological, drug and gene delivery, 
foods, foods additives and ingredients, food processing, cosmetic, textiles, industrial and ana-
lytical. Currently, patents on CDs are counted by thousands.
2. Inclusion complexes
An inherent interest surrounds these compounds due to their physical and chemicals proper-
ties [26–38]. The common feature of CDs is their ability to form inclusion complexes with a 
variety of molecules and ions, both in the solid state (crystalline substances) and in solution. 
As results of the structure of CDs, they can establish apolar-apolar interactions encapsulating 
other apolar molecules which may undergo structural changes [33–38], acting as molecular 
capsules [27–32]. However, the idea that one molecule could envelop another one to form a 
Figure 2. Steric structures of molecules from (a) α, (b) β, and (c) γ-CDs.
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new compound (adduct, inclusion complex) was not accepted until X-ray diffraction showed 
the formation of an inclusion complex between α-CD and iodine [37]. They constitute a sig-
nificant example of relatively simple organic compounds showing complex formation with 
other organic molecules. They are excellent models of enzymes that lead to their use as cata-
lysts [21, 24, 39], both in enzymatic and non-enzymatic reactions. Additionally, they are natu-
ral products and readily available to most researchers.
It is accepted [18, 38, 40–43] that the binding forces involved in complex formation are, in 
general:
i. van der Waals type interactions (or hydrophobic interactions) between the hydrophobic 
unit of the guest molecules and the CD cavity.
ii. Hydrogen bond between the polar functional groups of the guest molecules and the hy-
droxyl groups of the CD.
iii. Release of high energy water molecules from the cavity in the complex formation process.
iv. Release of strain energy into the ring structure system of the CD.
The role of the hydrogen bond is not universal since stable complexes are formed with hosts 
such as benzene, which do not form hydrogen bonds.
2.1. Factors affecting stability
Regardless of which type of stabilizing force is involved, the most important factors in deter-
mining the stability of the inclusion complex are [36, 40–45]:
the geometric capability
polarity of the guest molecules
the medium
temperature
Geometric, rather than chemical factors, are critical in determining the type of “guest” mol-
ecules that can penetrate into the cavity. If the guest is too small, it passes easily through the 
cavity and the bond will be weak or will not occur. The formation of complexes with mol-
ecules significantly larger than the cavity is also possible, but only some limited groups or 
side chains penetrate into the CD cavity.
The stability of an inclusion complex also depends on the polarity of the “guest” molecule. 
Only substrates that are less polar than water may form inclusion complexes with the CDs. 
The stability of a complex is proportional to the hydrophobic character of the “guest” mol-
ecule. Highly hydrophilic molecules form complex CDs very weakly or do not complex at all.
On the other hand, stability depends heavily on the nature of the medium used for complex-
ation. In principle, the inclusion complexes may be formed either in solution [46–49] (generally 
carried out in the presence of water) or in the crystalline [40, 50–52] state. Although the forma-
tion of inclusion complexes also takes place [53] in an organic solvent, the guest molecules 
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are weakly complexed. Additionally, although a 1:1 stoichiometry between the substrate and 
the CD molecule is typical [46, 54–56], with certain systems (Figure 3), 1:2 and 2:1 complex 
formations are possible. Experimentally determined formation constant can be the function 
(Figure 4) of the formation constants of the isomeric complexes [46]. In addition, substitu-
tion of one or more hydroxyls results in most cases in better water-soluble derivatives. For 
example, CDs can be polymerized [32, 36, 40, 42, 44, 45, 57] by suitable bio- or polyfunctional 
agents to oligomers, long-chain polymers or crosslinked or immobilized networks in vari-
ous supports. Low molecular weight oligomeric CDs are readily soluble in water. Polymers 
(molecular mass over 10,000) are swollen gels which can be prepared in bead forms. The rigid 
structure of CDs “host” translates into well-defined and differentiated inclusion complex 
depending on the nature of the “guest” molecule.
Figure 3. Complexes of α-CDs and 1,4-disubstituted benzene [13].
Figure 4. Isomeric complexes from substrate and free ligand [55].
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Finally, the stability of the inclusion complex, in general, decreases when temperature 
increases [46]. Enthalpy and entropy changes can be obtained from the temperature depen-
dence of the equilibrium constant. An important issue, often overlooked in the CD field, is 
that the magnitudes of the standard free energy and entropy changes are dependent on the 
standard state chosen by the experimentalist.
3. Analytical and physicochemical applications
In the last years, CDs and their derivatives have been used in a variety of fields of analytical 
chemistry, especially in analytical separations [45, 58–63]. Spectral properties of CD and guest 
molecules can be altered due to the changes of the electrons distribution in the CD hole. CDs 
are used as reagent in different analyses such as UV-visible spectrophotometry, fluorescence 
[64, 65], phosphorescence [66, 67], and nuclear magnetic resonance methods [45, 68, 69].
The complexation of the analyte and/or the colored reagent can effectively change its prop-
erties. Among the most notable uses of this effect are: (i) enhancing the solubility of polar 
or non-polar analyte; (ii) enhancing the stability in polar or non-polar solution of reagents 
and colored complexes; (iii) increasing UV-visible absorption which improves the sensitiv-
ity of the colored reactions; and (iv) enhancing colored reactions selectivity. Luminescence 
techniques, in terms of fluorimetry and phosphorimetry, have reached a rapid development 
in routine analysis. However, many compounds luminesce very weakly in aqueous solution 
and the addition of CDs protects the excited (singlet or triplet) states of the possible dampers 
present in the solution since the rotation of the molecules is impeded due to the formation of 
the complex of inclusion with the result of a decrease in vibrational relaxation processes. The 
formation of inclusion complexes also increases the quantum fluorescence yield and hence 
the fluorescence intensities of numerous compounds. Sensitivity to certain characteristic reac-
tions also increases.
CDs also increase the emission intensity of the chemiluminescent reactions. This improve-
ment can be attributed to a number of factors, including an increase in the reaction rate and 
a greater efficiency in the process of excitation and protection of species that emit quench-
ing phenomena. One of the most relevant applications of CDs is to allow the observation of 
phosphorescence at room temperature [67]. This is because they protect the excited triplet 
state of the molecules of the shock absorbers present in the solution, and in the case of 
molecular quenching phosphorescence. They are used as chiral reagents in NMR. In many 
cases, the formation of inclusion compounds modifies the general characteristics and chemi-
cal shifts of two enantiomers. Differences in the chemical shifts of two diastereoisomers 
can be used for the determination of the isomeric purity of the samples. The formation of 
inclusion complexes can very significantly modify the redox characteristics [13, 70, 71] of 
the included molecules. Voltammetric sensors capable of responding to anionic compounds 
have been developed. The changes produced after the complexation (selective interac-
tion) allow the voltammetry to be used in the study of the complexation between CDs and 
organic molecules.
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CDs increase the selectivity of chromatographic separations [72–74], because the separa-
tion process is more selective than that between the eluent and the stationary phase alone. 
In HPLC, the application of the CDs has achieved a spectacular success. Their incorpora-
tion into the mobile phase allows improving the separations, since they are soluble in water 
and provide reversible and selective complexation. In addition, they are stable and show no 
 absorption in the UV-visible region of the electromagnetic spectrum. These characteristics 
mean that CDs are generally used in reverse phase separation processes, achieving the sepa-
ration of isomers, diastereoisomers, and enantiomers [75–78]. The high resolution obtained 
is due to the differences in the stability constants of the complexes in the mobile phase and 
the different adsorption of these complexes in the stationary phase. CDs may also be incor-
porated as support for the stationary phases. Capillary electrophoresis has also found use in 
chiral analytical separations [79–82].
4. A primer on pharmaceutical, food and cosmetic cyclodextrin 
studies
4.1. Bioavailability
CDs have mainly been used as complexing agents to improve the aqueous solubility of mol-
ecules. This allows the use of CDs to reduce or prevent gastrointestinal or ocular irritation 
by lowering the local concentration of the free drug below the irritancy threshold. Also, 
unpleasant odor or taste of drugs can be hidden by complexation of the functional groups 
that produce them with CDs, occulting them from the sensory receptors [83–85], furthermore, 
reducing their hydrophobicity using CDs. Finally, CDs can increase percutaneous or rectal 
absorption of drugs and their derivatives can increase the guest molecule bioavailability [84]. 
Recently, CDs and their derivatives have been used in dispersed vehicle systems such as 
emulsions, microcapsules, microspheres, nanospheres, nanocapsules, liposomes, and beads 
[86]. Additionally, the host-guest property allows CDs to be used as building blocks in supra-
molecular chemistry [7]. Suvarna et al. [87] explain an insight in the use of CDs to increase 
the bioavailability to resolve the problem of solubility and stability of phytochemicals. The 
authors describe that some chemicals as quercetin, curcumin, arteminsinin, resveratrol or 
naringenin increased their bioavailability due to the inclusion complexes with CDs. Authors 
concluded that CDs need to be more explored to cover some molecules that have potential 
biological activity but have not been approached.
4.2. Encapsulation
The encapsulation with CDs is gaining interest in different industries; this is reflected in the 
large number of publication and products related with it, such as drug delivery systems 
[7, 35]. This capacity of encapsulating compounds is used for a wide variety of things, among 
them is to protect the compounds, or to transport them to a target. This ability is due to the 
toroidal shape of CDs which makes possible to encapsulate hydrophobic molecules fully or 
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partially in their cavity [14, 35]. This characteristic let the CDs being used for oral, sublin-
gual, ocular, nasal, rectal, pulmonary, dermal, and other drug delivery systems, especially 
in systems of type 1/1 (one molecule per CD). The encapsulation with CDs enhanced the 
bioavailability of lipophilic drugs, as they are 17β-estradiol, androstenediol, clomipramine, 
and others. A limitation of CD in sublingual route is that the quantity used for a proper for-
mulation is too large to be considered. This increase in the bioavailability is also observed in 
the oral route for drugs such as diltiazem, flufenamic acid, molsidomine, salbutamol, having 
all of them a sustained release [88].
4.3. Controlled release
In order to optimize pharmacotherapy, drug release should be controlled in accordance with 
the therapeutic purpose and the pharmacological properties of the active substances. In recent 
years, the interest regarding the control of rate or time of delivery has significantly increased 
[88]. The multifunctional characteristics of CDs allow them to be used in most drug deliv-
ery systems [84]. The design process of drug delivery systems is currently more focused on 
the oral route, in which the release of the drug can be controlled by dissolution, diffusion, 
osmosis, density or pH. Challa et al. [89] give several examples of different uses in oral deliv-
ery. The use of β-CD increased the bioavailability of ketoprofen, terfenadine, and griseoful-
vin; but, the same CD, also demonstrated higher intensity or longer duration of therapeutic 
activity in tolbutamide or terfenadine. Although there are different effects depending on the 
modified CD used, for example, the solubility and dissolution rate can be increased using 
HP-β-CD, for drugs as albendazole, ketoprofen, phenytoin, and gliclazide; or an improve-
ment of hydrolysis stability γ-CD, for drugs as digoxin, camptothesin and paclitaxel. For oral 
administration, all CDs can be used because they are not toxic.
4.4. Nano
The improvement of the efficacy and bioavailability of poorly soluble drugs can be achieved 
by nanoparticles, which are stable systems that are used to create drug delivery systems 
[83]. Nanoparticles are 100–10,000 times smaller than human cells and their uses revolu-
tionize diagnosis, treatment, therapeutic efficacy, and patient compliance [83, 90]. However, 
nanoparticles are limited by their low drug loading and entrapment ability, which compro-
mises their safety and efficacy [84]. The use of CDs as a polymer increases the loading capacity 
of nanoparticle systems [89]. Furthermore, the optimal drug bioavailability and biodistribu-
tion can be achieved with a proper manipulation of physico-chemical and biological mecha-
nisms, which can be provided by the hybrid functionalities of CD nanosystems [91]. A new 
class of colloidal polymer is nanosponges, which consist of solid nanoparticles with colloidal 
shape and nanocavities. Examples of nanosponges are those based on CDs. It should be noted 
that the type, number, and position of the substituent on the CD affect the complexation abil-
ity of nanosponges. Thus, it is crucial to know which CD derivative to use. Tejashri et al. [92] 
expose the use of CD to make nanosponge, and the use of it to load drugs and use as carriers. 
The crosslinking of CDs with compounds, as carbonyl or dicarboxylate, creates the different 
types of nanosponge, polyamide, carbonate, etc. Authors concluded that this novel class of 
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CD-based nanosponge let drugs to be released in a controlled form at the target place, and its 
spherical shape let nanosponge to be administered as parental, aerosol, topical, tablets, and 
capsules forms.
4.5. Food
In last years the application of CDs in the food-industry have increased mainly due to the 
use of them as a protective agent against oxygen, to protect flavor of volatile compounds, 
to enriched food with vitamins and color components (such as anthocyanins) or to stabilize 
them [93, 94]. Another advantage for the food industry is that CD are tasteless, odorless, and 
non-caloric saccharides, and that they have an antidiabetic effect due to their low glycemic 
index and their capability to decrease the glycemic index of the food, and also to improve the 
cholesterol index. Human gastrointestinal enzymes cannot digest them, so it can be used as a 
dietary fiber, which is fermented by microflora, what makes them a prebiotic compound. All 
these properties make them nutraceuticals and bioactive food supplements [95, 96]. López-
Nicolás et al. [97] analyzed the positive effects of CDs in the encapsulation of antioxidant, and 
the repercussion on important factors as K
F
 or pH values. They also reviewed the antioxidant 
capacity of CDs, but they concluded that there is a necessity of more studies in this aspect.
4.6. Cosmetic
The cosmetic industry is looking for products with a good biological activity and adequate 
delivery on the skin [98]. The applications of CDs in cosmetics are similar to the pharmaceuti-
cal ones, e.g., stabilizing substances or increasing their solubility [99–101]. Centini et al. [98] 
associated ferulic acid, which is a photoprotector agent and an antioxidant compound, and 
CD. However, ferulic acid is not too much used due to the instability of it in the presence of 
air, UV-light, and heat; so, the aim of the work was to enhance the physico-chemical stabil-
ity. The authors concluded that the complex ferulic acid/CD have a better photostability and 
do not generate degradation products. Buschmann and Schollmeyer [99] explained the use 
of CD against the vaporization of slow release of the volatile compounds in perfumes; or 
the opposite, they also explained the use of CD to eliminate undesired odors, such as mer-
capto derivate used in waving lotion. More applications will become possible when CDs price 
decreases. CDs can also be used in the textile industry as depots of cosmetic molecules pro-
viding new cosmetic formulations.
4.7. Miscellaneous applications of cyclodextrins: tabular form
A more detailed picture of most recent selected applications in various areas, ranging from 
general reviews to inclusion complexes, metal and organometallic complexes, food, phar-
maceutical, pharmacological, medical and biomedical, environmental chemistry, personal 
care and toiletry, industrial, nanotechnological, industrial and analytical applications to 
enzyme, biomimetic, bioactive assembles and recognition, as well as miscellaneous appli-
cations is compiled in Table 1, which gives an idea of the importance and relevance of the 
CDs field. Figure 5 shows the number of publications cited per year, whereas in Figure 6, 
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Content Authors Refs.
General reviews
Overview about the work carried out on CDs concerning with: the 
general characteristics of CDs and derivatives, the preparation and 
evaluation of inclusion complexes, the use of CDs in the preparation 
of drug delivery systems, and their use for the preparation of 
biomaterials and nanoparticles.
Duchêne and Bochot (2016) [14]
Comprehensive overview on the methods used for analysis of CDs 
and CD-derivatives. The paper intends to act as a guide in looking 
around the classical and modern instrumental analytical methods 
suitable for identification, characterization and determination of CDs 
themselves, CDs in finished products or even in biological samples.
Szente et al. (2016) [2]
Current review on various aspects of CDs with regard to 
their chemical characteristics, properties, approaches used for 
complexation, characterization techniques, uses along with and future 
potential.
Khan and Durakshan (2013) [7]
Pharmaceutical applications of CDs with an emphasis on their 
solubilizing properties, their tendency to self-assemble to form 
aggregates, CD ternary complexes, and their metabolism and 
pharmacokinetics.
Kurkov and Loftsson (2013) [3]
Overview about several aspects related to the physico-chemical 
properties of CDs and their potential applications illustrated by recent 
examples.
Venturini et al. (2008) [102]
Inclusion complexation and CDs: physicochemical parameters of 
the guest molecule and improvements in the molecule’s solubility, 
stability, taste, safety, bioavailability, etc.
Mosher and Thompson (2007) [103]
CDs and their use in industrial products, technologies and analytical 
methods.
Martin del Valle (2004) [93]
Overview about past, present, and future of CD research. Potential 
uses of CDs in pharmaceuticals, foods, cosmetics, and chemical 
products and technologies.
Szejtli (2004) [26]
CDs: structure, complex formation, drug solubility and non-
conventional CD complexes.
Loftsson (2002) [9]
Scientific and technological aspects of CDs: from computational 
chemistry to industrial uses of CDs.
D’souza and Lipkowitz (1998) [104]
History (the three stages in the development of CD chemistry), 
fundamentals of CD chemistry and future trends.
Szejtli (1998) [105]
The properties and potential uses of CD derivatives: dimethyl- and 
dimethyl-βCD (DIMEB and TRIMEB).
Szejtli (1992) [106]
Catalyses by CDs leading to practical usages: covalent, non-covalent 
and asymmetric catalyses by CDs.
Bender and Komiyama (1978) [107]
Inclusion complexes
The inclusion complex of oxyresveratrol in modified CDs: a 
thermodynamic, structural, physicochemical, fluorescent and 
computational study.
Matencio et al. (2017) [108]
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Content Authors Refs.
Summary of method for inclusion complex formation of CD with its 
guests and its applications.
Cheirsilp and Rakmai (2016) [42]
Literature review to characterize the formation of inclusion complexes 
by different techniques in the solid and in the solution state 
complexation.
Maazaoui and Abderrahim 
(2015)
[44]
Use of CDs as complexing agents to enhance the solubility of poorly 
soluble drugs and hence to resolve the many issues associated with 
developing and commercializing poorly water-soluble drugs.
Chaudhary and Patel (2013) [16]
Survey of crystal structures of pure CD hosts and CD inclusion 
compounds carried out during the last six years. The entries range 
from simple alkylated derivatives to elegant multi-substituted target 
CD molecules, with and without included guests.
Caira (2011) [40]
CD inclusion of four phenylurea herbicides: determination of complex 
stoichiometries and stability constants using solution 1H NMR 
spectroscopy.
Smith et al. (2010) [69]
Comparison of the inclusion complexation between host and guest in 
CD chemistry with the coordination interaction between central ion 
(Mx+) and ligands in coordination chemistry.
Song et al. (2009) [36]
Threading CDs molecules onto polymer chains to form crystalline 
inclusion complexes organized by non-covalent interactions.
Martinez and Gomez (2007) [109]
Practical considerations in development of solid dosage forms that 
contain CD.
Miller et al. (2007) [110]
CD inclusion complexes with a solvatochromic fluorescent probe: 
an undergraduate physical chemistry lab experiment to establish 
the solvatochromic nature of PRODAN and then use the changes 
in the emission spectra upon inclusion in β- or γ-CD to determine 
stoichiometry and formation constants for the complexes.
Baker et al. (2002) [111]
Some applications of CD/ substrate inclusion complexes. Crini et al. (2001) [8]
Determination of thermodynamic parameters of the CD inclusion 
processes: an undergraduate physical chemistry lab experiment.
Valero et al. (1999) [112]
Complexation thermodynamics of CDs. Rekharsky and Inoue (1998) [113]
Applications of CDs to pharmaceutical industry and chemical 
catalysis. Analytical applications are also considered, since CDs 
inclusion improves the sensitivity and selectivity of most analytical 
methods.
Muñoz-Botella et al. (1995) [37]
β-CD inclusion complexes with iodine: an advanced and inexpensive 
undergraduate chemistry experiment.
Diaz et al. (1994) [114]
Critical overview about past, present and future of CDs: properties, 
studies on CD inclusion compounds and its applications.
Davies et al. (1983) [115]
Metal and organometallic complexes
Synthesis, reactivity and structural diversity of well-defined metal 
complexes derived essentially from native CDs. Structural motifs for 
metal complexes based on CDs: from monomeric species, dinuclear 
systems, homo- and heterometallic sandwich-type complexes to 
cylindrical, extended structures.
Prochowic et al. (2016) [116]
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Content Authors Refs.
Overview of recent advances of CD catalyzed reactions, which is 
organized in the order of the following reaction types: the modified 
CD catalyzed organic reaction, CD catalyzed organic reaction of metal 
ion present, CD catalyzed organic reaction without metal ion, and CD 
catalyzed organic reactions in application of asymmetric synthesis and 
photochemical reactions.
Hong et al. (2015) [117]
Research and application of CDs and their derivatives in asymmetric 
and stereospecific syntheses, with their division into three main 
groups: (1) CDs promoting asymmetric and stereospecific catalysis 
in water; (2) CDs’ complexes with transition metals as asymmetric 
and stereospecific catalysts; and (3) CDs’ non-metallic derivatives as 
asymmetric and stereospecific catalysts.
Macaev and Boldescu (2015) [118]
Preparation and analysis of CD-based metal–organic frameworks: 
laboratory experiments adaptable for high school students.
Smith et al. (2015) [49]
Selectively functionalized CDs and their metal complexes: recent 
applications as chiral receptors and catalytic center in the mimicking 
of metalloenzymes.
Bellia et al. (2009) [119]
Metal complexing properties of native CDs (including deprotonation 
in alkaline medium) and a report on some recent results on 
composition and stability of metal–CD complexes.
Norkus (2009) [120]
CDs as supramolecular hosts for organometallic complexes. Hapiot et al. (2006) [121]
Food applications
Complexation of poorly water-soluble phytochemicals (flavonoids, 
phenolic derivatives, coumestans to triterpenes) with CDs to 
improve their aqueous solubility, stability, rate of dissolution and 
bioavailability.
Suvarna et al. (2017) [87]
CDs in food technology and human nutrition: benefits and limitations. 
The recent applications of CDs for reducing unwanted components, 
such as trans-fats, allergens, mycotoxins, acrylamides, bitter 
compounds, as well as in smart active packaging of foods are also 
overviewed.
Fenyvesi et al. (2016) [95]
History, chemistry, methods of complexation and application of 
CDs into different areas, particularly in the pharmaceutical and food 
industry.
Maazaoui and Abderrahim 
(2015)
[44]
Properties, enzymatic production, and food applications of α-CD, as 
well as its differences with β- and γ-CDs.
Li et al. (2014) [122]
Studies on the complexes formed between several important types of 
antioxidant compounds and CDs.
López-Nicolás et al. (2014) [97]
Applications of CDs as food additives and in food processing: 
transport of previously nontransportable foods and prevention of the 
spread of microbial infections.
Martina et al. (2013) [123]
CDs as novel solutions for the food industry concerning with their role 
as dietary fiber, in food and drink with health-promoting additives, 
protect sensitive ingredients, improve taste and odor, or their 
positively influence to the texture and consistency of food.
Zipp (2012) [96]
Factors controlling flavors binding constants to CDs and their 
applications in foods.
Astray et al. (2010) [124]
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CD encapsulation of essential oils and volatiles: methods for the 
preparation of inclusion complexes, analytical techniques and 
applications.
Cabral Marques (2010) [33]
Practical aspects of the utilization of CDs and CD inclusion 
compounds to food manufacture, focusing on the technical advantages 
of their use in food processing and as food additives.
Moreira da Silva (2009) [125]
Use of CDs in the food industry: properties from a technological 
point of view, such as solubility and their capability to form inclusion 
complexes are described.
Astray et al. (2009) [94]
Isolation and identification of native and branched-type (glucosylated 
and maltosylated) CDs in different enzyme- and heat-processed 
starch-containing food products.
Szente et al. (2006) [35]
Practical aspects of the utilization of CDs and CD complexes in the 
food industry: molecular encapsulation of lipophilic food ingredients, 
long-term storage stability and technological advantages and food 
processing technologies.
Szente and Szejtli (2004) [126]
CDs: application to food processing. Yoshii (2004) [127]
Pharmaceutical applications
Reviews
CDs: history, chemical structure, synthesis, physicochemical 
properties, uses, complexation phenomenon, approaches for making 
inclusion complexes, and its characterisation, advantages of inclusion 
complexes, mechanism of drug release, regulatory status and its 
applications.
Kanaka Durga Devi et al. (2010) [83]
Basic science information and data on the development of drugs in 
CD-containing formulations.
Loftsson and Brewster (2010) [128]
Critical review about experimental methods for determination of the 
binding constant between CD and a guest molecule.
Funasaki et al. (2008) [10]
Historical development of CDs with emphasis on their use in 
pharmaceutical formulations.
Loftsson and Duchêne (2007) [129]
CD-based pharmaceutics: past, present and future applications. Davis and Brewster (2004) [130]
CDs: structure, complex formation and drug solubility and non-
conventional CD complexes.
Loftsson (2002) [9]
Main impetus for the research into CD-drug combinations. Frömming and Szejtli (1994) [131]
Delivery release
Application of CD nanosystems for oral drug delivery: strategies 
for the synthesis of these nanosystems, and their potential for 
the intelligent navigation of the gastrointestinal tract for optimal 
bioavailability and biodistribution.
Adeoye et al. (2017) [91]
CD-mediated hierarchical self-assembly and its potential in drug 
delivery applications.
Antoniuk and Amiel (2016) [132]
Supramolecular nanostructures based on CD and poly(ethylene 
oxide): syntheses, structural characterizations and applications for 
drug delivery.
Zheng and Wyman (2016) [133]
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Recent advances in drug delivery techniques utilizing CDs, and cyclic 
oligosaccharides consisting of α-1,4-linked α-D-glucopyranose units. 
Especially, drug delivery system consisting of combination systems of 
CDs and functional materials such as dendrimer, liposome and PEG 
are introduced.
Arima et al. (2015) [134]
Relationship between CDs structure and physicochemical 
characteristics: self assembly and drug delivery. Importance of the 
nanoparticle technology preparation for the stability and application 
of this nanodevice.
Bonnet et al. (2015) [135]
CD-based carriers for delivery of chemotherapeutic cytotoxic 
anticancer drugs.
Gidwani and Vyas (2015) [90]
CD-based delivery systems for arthritic diseases: from development to 
experimental therapeutics.
Nascimento et al. (2015) [136]
A vision for CD nanoparticles in drug delivery systems and 
pharmaceutical applications.
Lakkakula and Krause (2014) [137]
CD containing biodegradable particles: from preparation to drug 
delivery applications.
Zafar et al. (2014) [138]
State of the art and recent advances in the construction of CD-based 
assemblies and their applications for controlled drug delivery.
Zhang and Ma (2013) [139]
CD in drug delivery: complexing agents, bioavailability and industrial 
applications.
Chordiya Mayur and 
Senthilkumaran (2012)
[86]
Recent developments of CDs in drug delivery using various routes of 
administration.
Laza-Knoerr et al. (2010) [140]
Advantages of CD inclusion complexation, effects on important 
drug properties in formulation and applications in delivery systems 
(oral drug, rectal dug, nasal drug, transdermal drug, ocular drug, 
controlled and targeted drug, peptide and protein delivery, gene and 
oligonucleotide delivery, dermal and transdermal delivery, brain drug 
delivery or brain targetting).
Tiwari et al. (2010) [84]
CD-based supramolecular architectures: syntheses, structures, and 
applications for drug and gene delivery.
Li and Loh (2008) [141]
Applications of CDs and their derivatives in different areas of drug 
delivery: parenteral, oral, ophthalmic and nasal drug delivery. Other 
routes including dermal, rectal, sublingual and pulmonary delivery 
are also briefly addressed.
Rasheed et al. (2008) [88]
Applications and comparative benefits of use of CDs and their 
derivatives in the design of novel delivery systems like liposomes, 
microspheres, microcapsules, nanoparticles, CD grafted cellulosic 
fabric, hydrogels, nano- sponges, beads, nanogels/nanoassemblies and 
CD-containing polymers.
Vyas et al. (2008) [142]
The utility of CDs for enhancing oral bioavailability. Carrier et al. (2007) [143]
CDs as cosmetic delivery systems: study of ferulic acid/ CD 
association complexes at the light of its possible use as sunscreen.
Centini et al. (2007) [98]
Effects of hydrophilic CDs on drug permeation through membranes 
and possible mechanism of action based on the current knowledge of 
the structural characteristics of water and the unstirred water layer 
juxtaposed to the membrane of interest.
Loftsson et al. (2007) [144]
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Interesting findings and applications of CDs and their derivatives in 
different areas of drug delivery, particularly in protein and peptide 
drug delivery and gene delivery. Applications in the design of various 
novel delivery systems like liposomes, microspheres, microcapsules, 
and nanoparticles.
Challa et al. (2005) [89]
CDs in drug delivery. Pharmaceutical products worldwide containing 
drug/CD complexes on the market.
Loftsson et al. (2005) [145]
Recent findings and applications of both unmodified and modified 
CDs for in vivo drug delivery. Use of CDs for parenteral, oral, 
ophthalmic, and nasal drug delivery. Other routes including dermal, 
rectal, and pulmonary delivery are also briefly addressed.
Rajewski and Stella (1996) [54]
Carrier
Potential therapeutic application of dendrimer/CD conjugates with 
targeting ligands as advanced carriers for gene and oligonucleotide 
drugs.
Arima et al. (2017) [146]
Drug carrier systems based on CD supramolecular assemblies and 
polymers: present and perspectives.
González-Gaitano et al. (2017) [147]
CD-based polymeric nanoparticles as efficient carriers for anticancer 
drugs.
Duchêne et al. (2016) [148]
Potential use of chemically modified CDs as high-performance drug 
carriers in drug delivery systems with emphasis on the more recent 
developments.
Rasheed et al. (2008) [88]
CD drug carrier systems: characteristics, improvements of drug 
properties by CD complexation and CD-based drug delivery systems.
Uekama et al. (1998) [149]
Solubilization and permeation
CDs in pharmaceutical formulations: solubilization, binding constant, 
and complexation efficiency.
Jambhekar and Breen (2016) [18]
Use of CDs as complexing agents to enhance the solubility of 
poorly soluble drugs and issues associated with developing and 
commercializing poorly water soluble drugs.
Chaudhary and Patel (2014) [16]
Pharmaceutical applications of CDs: effects on drug permeation 
through biological membranes.
Loftsson and Brewster (2011) [150]
General background to the use of CD as solubilizers as well as 
highlight kinetic and thermodynamic tools and parameters useful in 
the study of drug solubilization by CDs.
Brewster and Loftsson (2007) [15]
CDs as solubilizers as well as highlight kinetic and thermodynamic 
tools and parameters useful in the study of drug solubilization
Loftsson and Brewster (1996) [19]
Protein
Use of CDs and their derivatives as antiaggregant agents in a number 
of proteins and some multimeric enzymes.
Oliveri and Vecchio (2016) [151]
CD-based multivalent glycodisplays: covalent and supramolecular 
conjugates to assess carbohydrate–protein interactions.
Martínez et al. (2013) [152]
CD interactions with protein-like structures in order to describe their 
possible applications in the formulation of pharmaceutical proteins.
Varca et al. (2010) [153]
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Encapsulation
Encapsulation of CD/drug inclusion complex into conventional, 
deformable and double loaded liposomes: characteristics of these 
systems and advantages and disadvantages of each one.
Gharib et al. (2015) [154]
Encapsulation of biocides by CDs: toward synergistic effects against 
pathogens.
Nardello-Rataj and Leclercq 
(2014)
[34]
Use of CDs as encapsulating agents for bioactive plant molecules in 
the pharmaceutical field.
Pinho et al. (2014) [35]
Excipients
Background review for CDs used as excipients. EMA/CHMP/333892/ (2013) [155]
CDs as functional excipients: methods to enhance complexation 
efficiency.
Loftsson and Brewster (2012) [156]
Formulations
CDs in pharmaceutical formulations: structure and physicochemical 
properties, formation of complexes, and types of complex.
Jambhekar and Breen (2016) [17]
Evaluation of CDs drug complexes in pharmaceutical formulation: 
preparation of sodium valproate phenytoin sodium/ β-CD inclusion 
complex in a trial to stabilize the drug against moisture absorption 
and forming non-hygroscopic powders and preparation of phenytoin 
sodium/β-CD inclusion complex in a trial to stabilize the drug against 
moisture absorption and mask its bitter taste.
Akasha et al. (2014) [157]
CDs in topical drug formulations: drug delivery from aqueous CD 
solutions by diffusion and membrane controlled.
Loftsson and Masson, (2001) [158]
Miscellaneous
Types of fluorophores which have been used for CD tagging: synthetic 
strategies used for the conjugation and pharmaceutical applications 
of these ‘visualized’ macrocycles including their use in photodynamic 
therapy.
Benkovics et al. (2017) [159]
CDs’ legacy as complexing agents and future prospects of this class 
of chemical entities in pharmaceutics as new active pharmaceutical 
ingredients.
di Cagno and Pio (2017) [160]
Use of CD in the different routes of drug administration. Shimpi et al. (2005) [161]
Recent findings on the safety profiles of three natural CDs and 
several chemically modified CDs: stability against non-enzymatic 
and enzymatic degradations in various body fluids and tissue 
homogenates and their pharmacokinetics via parenteral, oral, 
transmucosal, and dermal routes of administration.
Irie and Hekama (1997) [162]
Pharmacology
Production, physiochemical properties, pharmacokinetics, toxicity and 
applications of γ-CD and its derivatives.
Saokham et al. (2017) [15]
Interactions between CDs and cellular components: medical 
applications.
Leclercq (2016) [163]
Inclusion of terpenes in CDs: preparation, characterization and 
pharmacological approaches.
Lima et al. (2016) [164]
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Self-assembly of CDs and their complexes in aqueous solutions. Ryzhakov et al. (2016) [48]
Diagnostic utility of flow cytometry and improvement of rocuronium-
induced anaphylaxis with the use of sugammadex.
Takazawa et al. (2016) [165]
Sugammadex for reversal of rocuronium-induced neuromuscular 
blockade in pediatric patients: a systematic review and meta-analysis.
Won et al. (2016) [166]
Improving the therapeutic response of analgesic drugs by CDs. De Oliveira et al. (2015) [167]
Types of CDs, and their efficacy, physicochemical properties and 
transformation into nanoparticles with interesting in vitro and in vivo 
applications.
Lakkakula and Krause (2014) [137]
Potential therapeutic use of CDs and CD nanoparticles in 
neurodegenerative diseases, stroke, neuroinfections and brain tumors.
Vecsernyés et al. (2014) [168]
Basic and clinical pharmacology of sulfobutylether-β-CD. Loftsson and Brewster (2010) [128]
Basic and clinical pharmacology of sulfobutylether-β-CD. Luke et al. (2010) [169]
CD introduction to anesthesia practice: form, function, and 
application.
Welliver (2007) [170]
Findings on the safety profiles of three natural CDs and several 
chemically modified.
Irie and Uekama (1997) [162]
Medical and biomedical
Key features of the CDs therapeutic discovery. Application of 
computational chemistry approaches such as QSAR/QSPR, molecular 
docking, and molecular/quantum mechanics for modeling of CD-drug 
system.
Abdolmaleki et al. (2017) [171]
Recent development of copolymeric delivery system for anticancer 
agents based on CD derivatives.
Feng et al. (2016) [172]
General features and applications of CDs and their interactions 
with isolated biomolecules leading to the formation of inclusion or 
exclusion complexes: potential medical applications.
Leclercq (2016) [163]
Data on the general properties and complexing ability of CDs and 
assessment methods (phase solubility, DSC tests and X-ray diffraction, 
FTIR spectra).
Radu et al. (2016) [173]
CD interactions with protein-like structures: possible applications in 
the formulation of pharmaceutical proteins.
Vecsernyés et al. (2014) [168]
Amphiphilic CDs and their applications: preparation of nanoparticles 
based on amphiphilic CDs for biomedical applications.
Parrot-Lopez et al. (2010) [174]
A supramolecular approach to medicinal chemistry: essential roles 
played by intermolecular forces in mediating the interactions between 
chemical molecules and biological systems.
Smith (2005) [175]
Medicinal applications of CDs: improvement of drug properties, use 
of drug/CD complexes, CDs in tabletting and direct treatment with 
CDs.
Szejtli (1994) [176]
Environmental Chemistry and Applications
Nanosponge CD polyurethanes and their modification with 
nanomaterials for the removal of pollutants from waste water.
Leudjo Taka et al. (2017) [177]
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Progress in the immobilization of β-CD and their application in 
adsorption of environmental pollutants.
Han et al. (2016) [178]
Interactions of CDs and their derivatives with toxic organophosphorus 
compounds.
Letort et al. (2016) [179]
CD inclusion of four phenylurea herbicides: determination of complex 
stoichiometries and stability constants using solution 1H NMR 
spectroscopy.
Smith et al. (2010) [69]
Fluorescence spectroscopy as a tool to study the properties of CD 
host-guest complexes. Overview of recent studies concerned with 
exploiting the properties of CDs and their inclusion complexes to 
study energy transfer through the use of photochemical antennas and 
the development of chemical and environmental sensors.
Fakayode et al. (2007) [27]
Synthesis and applications of adsorbents containing CDs in the field of 
chromatographic separations and in waste water treatment.
Crini and Morcellet (2002) [180]
Personal care and toiletry
CDs as cosmetic delivery system: study of ferulic acid/CD association 
complexes.
Centini et al. (2007) [98]
Inclusion complex formation of CD with its guest and their 
applications in foods and flavors, personal care and toiletry, 
environment protection, pharmaceuticals among others.
Cheirsilp and Rakmai (2016) [42]
Possible applications of CDs in cosmetic products and some examples 
of their present uses.
Buschmann and Schollmeyer 
(2002)
[99]
Industrial applications
Enabling technologies and green processes in CD chemistry: 
microwaves, ultrasound and ball mills have become irreplaceable tools 
in the synthesis of CD derivatives. Examples of sonochemical selective 
modification of native α-, β- and γ-CDs including heterogeneous 
phase Pd- and Cu-catalysed hydrogenations and couplings.
Cravotto et al. (2016) [181]
Major fields of enzyme application and overview on previous protein 
engineering studies wherein natural enzymes were modified to meet 
the operational conditions required for industrial application.
Jemli et al. (2016) [24]
Applications of CDs in medical textiles: general data properties and 
complexing ability of CDs and assessment methods (phase solubility, 
DSC tests and X-ray diffraction, FTIR spectra, analytical method).
Radu et al. (2016) [173]
Applications of CDs in various industrial products, technologies, 
analytical and chemical processes and recent industrial advancements.
Sharma and Baldi (2016) [182]
General features of β-CD and their applications in the textile industry: 
attachment technique of β-CD to the textile’s surface.
Bhaskara-Amrit et al. (2011) [183]
CDs in pharmaceutics, cosmetics, and biomedicine: current and future 
industrial applications.
Bilensoy (2011) [184]
Role of CDs in the textile chemical technology: remove the surfactants 
from the material or to inactivate them in liquid phase, to intensify the 
enzyme processes or as balancers in dyeing with reactive pigments.
Grigoriu and Popescu (2011) [185]
Amphiphilic CDs and their applications. Preparation of nanoparticles 
based on amphiphilic CDs for biomedical applications.
Parrot-Lopez et al. (2010) [174]
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Applications of CDs in pharmaceuticals with a major emphasis on 
drug delivery systems. Utility in a variety of foods, flavors cosmetics, 
packaging and textiles.
Singh et al. (2002) [186]
Applications of CDs in pharmaceuticals, foods and flavours, 
cosmetics, chemical industry, agricultural industry and adhesives, 
coatings and other polymers.
Arenskötter et al. (2001) [187]
Industrial applications of CDs. Production and analysis of complexes. Hedges (1998) [188]
Utilization of CDs in industrial products and processes: (i) textiles, 
fibers and papers; (ii) foods and cosmetics; (iii) plastics and rubber; 
(iv) photographic and recording materials; (v) biotechnology and (vi) 
environmental protection.
Szejtli (1997) [189]
Overview about industrial uses of CDs and their derivatives. Duchêne and Wouessidjewe 
(1992)
[190]
CD inclusion compounds in research and industry: production of 
pharmaceuticals, pesticides, foodstuffs, and toilet articles among 
others.
Saenger (1980) [191]
Nano
General overview of CDs and pharmaceutical nanotechnology in oral 
delivery systems. Strategies for the synthesis of these nanosystems, 
and their potential for the intelligent navigation of the gastrointestinal 
tract for optimal bioavailability and biodistribution.
Adeoye and Cabral-Marques 
(2017)
[91]
Nanosponge CD polyurethanes and their modification with 
nanomaterials for the removal of pollutants from waste water.
Leudjo et al. (2017) [177]
CD-based supramolecular host–guest interactions for engineering 
supramolecular nanoparticles: biomedical applications.
Mejia-Ariza et al. (2017) [192]
CD-based polymeric nanoparticles as efficient carriers for anticancer 
drugs.
Duchene et al. (2016) [148]
CD-based nanosponges: a versatile platform for cancer 
nanotherapeutics development.
Swanimathan et al. (2016) [193]
Supramolecular nanostructures based on CD and poly(ethylene 
oxide): syntheses, structural characterizations and applications for 
drug delivery.
Zheng and Wyman (2016) [133]
Nano-sized CD-based molecularly imprinted polymer adsorbents for 
perfluorinated compounds.
Karoyo and Wilson (2015) [194]
Overall view of the diversity of designs of CD-based supramolecular 
nanosystems with a special focus on the advances materialized in the 
last five years, including clinical trials.
Simoes et al. (2015) [195]
Recent advances in the construction of nanoassemblies driven by 
CD-based inclusion complexation and their application in biomedical 
and biomimetic fields.
Kang et al. (2014) [196]
A vision for CD nanoparticles in drug delivery systems and 
pharmaceutical applications.
Lakkakula and Krause (2014) [137]
Approaches tested to synthesize nano- to macro-size covalently cross-
linked CD networks: (i) direct cross-linking through condensation 
with di- or multifunctional reagents, (ii) copolymerization of CD 
derivatives with acrylic/vinyl monomers, and (iii) grafting of CDs to 
preformed medical devices.
Concheiro and Alvarez-Lorenzo 
(2013)
[197]
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Development of nanosponges as drug delivery systems, with special 
reference to CD based nanosponges.
Tejashri et al. (2013) [92]
Preparation, characterization and advantages for pharmaceutical and 
biomedical applications of CD-based nanogels.
Moya-Ortega et al. (2012) [198]
Formation and applications of CD nanoaggregates induced by guest 
molecules, the concerned thermodynamics behind the process and the 
effect of concentration of the guest molecules on the morphology of 
the aggregates.
Purkayastha et al. (2012) [199]
Approaches employed in delivering drugs to the central nervous 
system. Changes in blood-brain barrier function in several 
neurological disorders.
Martín-Banderas et al. (2011) [200]
Fabrication technologies of supramolecular systems including 
nanoplatforms and hydrogels as well as their applications in 
nanomedicine and pharmaceutical sciences.
Zhang and Ma (2013) [139]
Classification, physicochemical properties, efficacy and safety of 
nanoparticles prepared from different amphiphilic CDs are discussed 
in light of the current literature work with in vitro and in vivo findings.
Bilensoy and Hincal (2009) [201]
Analytical and physicochemical applications
Reviews
Classical and modern instrumental analytical methods suitable for 
identification, characterization and determination of CDs themselves, 
CDs in finished products or even in biological samples.
Szente et al. (2016) [2]
CDs in in sample preparation, sensitivity and selectivity improvement, 
enantio-separation, creating single-molecule sensors, and 
automatizing DNA sequencing.
Szente and Szeman (2013) [28]
CDs: from molecular recognition to CDs as enzyme models. 
Reactivity and chemistry, chromatography, X-ray, NMR plus other 
physicochemical methods, as well as model calculations, rotaxane and 
catenane structures, and applications in the pharmaceutical industry 
are overviewed.
Dodziuk (2006) [202]
Use of CDs in major areas of analytical chemistry such as 
chromatography, electrophoresis, spectroscopy, electrochemistry and 
as analytical sensors.
Mosinger et al. (2001) [203]
Role of CDs in three of the major areas of modern instrumental 
analysis: separations, spectroscopy and electrochemical analysis.
Armstrong (1998) [204]
Chirality
CD-functionalized monolithic capillary columns: preparation and 
chiral applications.
Adly et al. (2016) [205]
Recent developments in CD functionalized monolithic columns for the 
enantioseparation of chiral drugs.
Guo et al. (2016) [206]
Advances on the use of CDs in the chiral analysis of drugs by capillary 
electrophoresis.
Saz and Marina (2016) [80]
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Recent contributions to the understanding of the binding 
mechanism between chiral selectors and selectands in analytical 
enantioseparations including polysaccharide derivatives, CDs, 
cyclofructans, macrocyclic glycopeptides, proteins, brush-type 
selectors, ion-exchangers, polymers, crown ethers, ligand-exchangers, 
molecular micelles, ionic liquids, metal-organic frameworks and 
nucleotide-derived selectors.
Scriba (2016) [77]
Development of cationic CDs for chiral separation. Update of the 
research endeavors of synthetic and analytical chemists in evaluating 
enantioselectivity of cationic CDs using different analytical methods 
and the study of the chiral recognition mechanism.
Zhou and Scriba (2016) [75]
Advances in enantiomeric resolution on monolithic chiral stationary 
phases in liquid chromatography and electrochromatography.
Al-Othman et al. (2014) [207]
Recent examples of mechanistic aspects of capillary enantioseparations 
with regard to mathematical modeling of enantioseparations, 
investigations of the analyte-complex structures as well as new chiral 
selectors and applications of chiral analyses by CE and CEC.
Jac and Scriba (2013) [208]
Review of the latest advances in developing modified CDs as 
chiral selectors for various chromatographic and electromigration 
techniques.
Tang et al. (2013) [76]
Chiral analysis of amphetamines, methadone and metabolites in 
biological samples by electrodriven methods.
Mandrioli et al. (2011) [209]
The growth and applications of CDs as chiral discriminator. Pathak and Pathak (2008) [210]
CDs in capillary electrophoresis enantioseparations: recent 
developments and applications.
Scriba (2008) [90]
Separation of enantiomeric barbiturates by capillary electrophoresis 
using a CD containing run buffer: a laboratory experiments for degree 
students.
Contradi et al. (1997) [82]
Complexes characterization
Physicochemical characterization of CD-drug interactions in the solid 
state and the effect of water on these interactions.
Ogawa and Takahashi (2015) [52]
Analytical techniques for characterization of CD complexes in the 
solid state.
Mura (2015) [51]
Analytical tools which can be employed for the characterization of 
drug-CD inclusion complexes in solution, with emphasis on their 
respective potential merits, disadvantages and limits.
Mura (2014) [47]
Surfactant-CD host-guest association: fundamentals, drawbacks 
and advantages of techniques commonly used to obtain insights on 
the structural and bulk solutions changes resulting from host-guest 
association mechanism, and corresponding methods for binding 
quantification.
Valente and Söderman (2014) [30]
CD inclusion complexes probed by NMR techniques. Pessine et al. (2012) [45]
A literature review of CD inclusion complexes characterization: X-ray 
diffraction, infrared spectroscopy and nuclear magnetic resonance.
Takahashi et al. (2012) [211]
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A literature review of CD inclusion complexes characterization: 
differential scanning calorimetry and thermogravimetry.
Takahashi et al. (2012) [68]
A bilogarithmic method for the spectrophotometric evaluation of 
stability constants of 1:1 weak complexes from mole ratio data.
Boccio et al. (2006) [212]
NMR studies of CDs and CD complexes. Comprehensive overview 
about the most important approaches to structural problems with 
CDs, mainly in solution.
Schneider et al. (1998) [213]
The stability of CD complexes in solution: binding equilibria and 
kinetics, strengths and structures of CD complexes, the sources of CD 
complex stability and prediction of CD complex stability.
Connors (1997) [46]
Separation Methods
State-of-the-art applications of CDs as functional monomers in 
molecular imprinting techniques.
Lay et al. (2016) [214]
CDs in capillary electrophoresis: recent contributions, practical uses 
(e.g. solute-CD binding constant estimation and further potentials), 
developments and applications (mainly chiral and achiral analysis).
Recent developments and new trends.
Escuder-Gilabert et al. (2014) [79]
Separation processes in the presence of CDs using molecular 
imprinting technology and ionic liquid cooperating approach.
Zhang et al. (2011) [59]
Role of CDs in chromatography. Influence of The formation the 
physicochemical parameters of the guest molecule (adsorption 
capacity, polarity, hydrophobicity, etc.).
Cserhat and Forgaes (2003) [71]
Summary of the information concerning the synthesis of materials 
containing CDs and general overview of the different possible 
applications of CDs as sorbents in the field of separation techniques.
Crini and Morcellet (2002) [180]
CDs as a versatile tool in separation science. The techniques 
examined include gel electrophoresis, isotachophoresis, isoelectric 
focusing, preparative scale electrophoretic techniques, thin-
layer chromatography, electrochemically modulated liquid 
chromatography, use of monolithic media in liquid chromatography, 
microdialysis, separation on hollow fibers, foam flotation 
enrichment, solid- and liquid-phase extractions, countercurrent 
chromatography, separation through liquid and composite 
membranes, and CD applications in molecularly imprinted 
polymers.
Schneiderman and Stalcup (2000) [61]
Utilization of CDs and their derivatives in gas-liquid and gas-solid-, 
gel-, inclusion-, thin-layer-, affinity-, and high performance liquid 
chromatography.
Szejtli (1987) [215]
Applications of CDs in chromatographic separations and purification 
methods.
Hinze (1981) [73]
Spectrofluorometric Methods
Spectrofluorometric analytical applications of CDs based on host-
inclusion complex.
Elbashir et al. (2014) [64]
Room temperature phosphorescence in CDs: analytical applications. Muñoz de la Peña et al. (2000) [66]
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Electrochemical Methods
Advantages and detecting mechanism of electrochemical sensors 
based on CDs functionalized materials, and recent advances for CDs-
based materials (including CDs/carbon nanotubes, CDs/graphene, 
CDs/conducting polymers and other CDs-based nanomaterials) in 
electrochemical sensing.
Zhu et al. (2016) [70]
Substrate/analyte solubilization and stabilization to the development 
of CD based sensors and detectors.
Szente and Szejtli (1998) [216]
State of the art of the electrochemistry of α-, β-, and γ-CDs and CD 
inclusion complexes and their polarographic and voltammetric assay.
Bersier et al. (1991) [71]
Enzyme—Biomimetic-Bioactive assemblies recognition
General overview of three different categories of CD-based artificial 
enzymes including metal free CD-based artificial enzymes, CD-based 
artificial metalloenzymes and CD-based artificial enzymes with 
computational design, focusing on their rate acceleration factor.
Aghahosseini and Ramazani 
(2016)
[21]
Major fields of enzyme application and overview on previous protein 
engineering studies wherein natural enzymes were modified to meet 
the operational conditions required for industrial application.
Jemli et al. (2016) [24]
Macromolecules based on recognition between CD and guest 
molecules: synthesis, properties and functions.
Liu et al. (2015) [217]
Representative contributions in the construction and the structural 
characteristics of CD-based supramolecular assemblies and their 
interactions with biologically important substrates.
Chen and Liu (2010) [218]
New chemistry based on the principles used by Nature: biomimetic 
chemistry.
Breslow (2009) [23]
Literature overview on reactions in which CDs bind substrates and 
then either catalyze their reactions or mimic a step in an enzymatic 
catalytic sequence.
Breslow and Dong (1998) [22]
Adjusting the lock and adjusting the key in CD chemistry. An 
introduction in biomimetic chemistry.
Breslow (1980) [219]
Miscellaneous
Functioning via host–guest interactions: achievement of selective 
molecular adhesion, self-healing, toughness, and actuation properties. 
These functions have been achieved by reversible bond formation with 
CDs.
Takachima and Harada (2017) [29]
Qualitative and quantitative analysis of research outputs on molecular 
modeling in CDs.
Zhao et al. (2017) [220]
Supramolecular polymer assembly in aqueous solution arising 
from CD host-guest complexation. Effects of such complexation on 
properties at the molecular and macroscopic levels.
Wang et al. (2016) [32]
Superstructures with CDs: chemistry and applications. Wenz and Monflier (2016) [221]
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the number of papers cited by journal for the most cited journal (number of references ≥2) 
appears. Emphasis is stressed on reviews and taking into account the high number of refer-
ences available, the authors apologize for those they may have overlooked or inadvertently 
omitted.
Content Authors Refs.
Synthesis of CD half-channels derived by per-functionalization of the 
CD primary positions and their activity as channels assessed by the 
bilayer clamp technique.
Chui and Fyles (2014) [222]
Construction of supramolecular structures of CDs with some 
polymers (polyrotaxanes) and formation of supramolecular oligomers 
and polymers formed by CD derivatives.
Harada et al. (2009) [223]
Systematic analysis of methods that are available for modification of 
CDs. The focus is on methods for transformation where the number 
and the exact positions of modifications are ascertained and pure 
compounds with unambiguous structures are obtained.
Khan et al. (1998) [224]
Applications of computational chemistry to the study of CDs: 
molecular modeling, structural features of CDs, dynamical aspects of 
CD structure and computational studies of host−guest complexation.
Lipkowitz (1998) [225]
CD-based catenanes and rotaxanes. Nepogodiev et al. (1998) [226, 227]
Organic reactions mediated by CDs: effect in solid CD complexes. Takahashi (1998) [228]
Table 1. Selected papers on food, pharmaceutical, pharmacology, cosmetic, industrial, and analytical applications of 
cyclodextrins (CDs).
Figure 5. Number of publications cited per year.
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5. Conclusion
Currently, there are a large number of drugs with poor solubility, bioavailability, permeability 
issues, undesirable properties as taste and odor, and irritation potential, and CDs can become 
an useful tool for optimizing drugs problematic [84]. Additionally, new uses of cyclodextrins 
are being explored, in different fields as nanoparticles, liposome and microsphere. The ability 
of making inclusion complexes with drugs makes CDs have a great future, as reflected by the 
rising number of publications and patents having been filed. Some researchers also believe that 
there will be more a still wider use for CDs as the knowledge about their properties increase [7]. 
The studies of CD-based nanosystems have recently increased, as they become platforms pro-
viding pharmacokinetic and formulation design efficiency without posing security problems 
[91]. CDs are also generating interest for gene therapy and exploration of non-viral methods, 
Figure 6. Number of papers cited by journal.
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probably for the difficulties in viral gene delivery [7]. A new area which is going to increase, is 
the study of the effects of the environment in the reactivity between CD-guest molecules [115]. 
The creation of new types of CD is going to enhance due to the wide range of possibilities in the 
treatments of atherosclerosis, cancer, and degenerative brain disease that are considered lethal 
disease [160]. CDs will surprise us in the future with not predictable uses [184].
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